Psychedelic-assisted therapies
The past, and the need to move forward responsibly
Bibliographic Data
| ID | 14905929 |
|---|---|
| Authors | John Gardner (0000-0001-7417-348X, Menzies School of Health Research, corresponding author), A Carter (0000-0002-3593-0772, Monash University), Kerry O’brien (0000-0003-3145-6038, Monash University), Kate Seear (0000-0002-0886-7069, Monash University) |
| Year | 2019 |
| Volume | 70 |
| Pages | 94-98 |
| Publication date | 2019-08-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2019.05.019 |
| PMID | 31136924 |
| OpenAlex | W2945745191 |
| Language | EN |
| Citations received | 7 |
| References cited | 33 |
Context (archaeology · Hallucinogen · Psilocybin · Psychiatry · Psychotherapist · Stigma (botany · Biochemical Analysis and Sensing Techniques · Chemical synthesis and alkaloids · Medicine · Psychedelics and Drug Studies · Psychology
Psychedelic-Assisted Psychotherapy
Australian psychologists' attitudes towards psychedelic‐assisted therapy and training following a world‐first drug down‐scheduling
The frontiers of new psychedelic therapies
Biological studies of clavine alkaloids targeting CNS receptors
Examining the Perspectives of Key Stakeholders on the Problems, Policies, and Politics Regarding Accessing Psychedelic Interventions to Alleviate End‐of‐Life Distress
Examining Volunteer Bias in Psychedelic Research
Exploring Public Sentiments of Psychedelics Versus Other Substances
Global, regional, and national burden of neurological disorders, 1990–2016
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Psilocybin with psychological support for treatment-resistant depression
Human hallucinogen research
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
Psychedelics
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Psilocybin-assisted treatment for alcohol dependence
Hitting Highs at Rock Bottom’
Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research
Acid Hype
Promissory identities
Psychedelic Drugs Reconsidered
| Citations per year | 1.75 |
|---|---|
| Citation span | 2022 - 2026 (5) |
| Highly cited | No |